Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta‐mediated neurotoxicity

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Neurochemistry

• Publication date

  2016-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/jnc.13514PMID 26710111
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Upregulation of Shiga Toxin Receptor CD77/Gb3 and Interleukin‐1β Expression in the Brain of EHEC Patients with Hemolytic Uremic Syndrome and Neurologic Symptoms

  2015cited by this paper
• The sheddase ADAM10 is a potent modulator of prion disease

  2015cited by this paper
• Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease

  2015cited by this paper
• Shedding light on prion disease

  2015cited by this paper
• A potential function for neuronal exosomes: Sequestering intracerebral amyloid‐β peptide

  2015cited by this paper
• Exosomes: Mediators of Neurodegeneration, Neuroprotection and Therapeutics

  2014cited by this paper
• Myeloid microvesicles in cerebrospinal fluid are associated with myelin damage and neuronal loss in mild cognitive impairment and Alzheimer disease

  2014cited by this paper
• Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease.

  2014cited by this paper
• MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer's disease.

  2014cited by this paper
• Decreased Amyloid-β Pathologies by Intracerebral Loading of Glycosphingolipid-enriched Exosomes in Alzheimer Model Mice*

  2014cited by this paper
• High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.

  2014influential reference
• Microglia convert aggregated amyloid-β into neurotoxic forms through the shedding of microvesicles

  2013influential reference
• An N-terminal Fragment of the Prion Protein Binds to Amyloid-β Oligomers and Inhibits Their Neurotoxicity in Vivo*

  2013cited by this paper
• Neurotoxic amyloid beta oligomeric assemblies recreated in microfluidic platform with interstitial level of slow flow

  2013cited by this paper
• Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein.

  2013cited by this paper
• Prion Protein-mediated Toxicity of Amyloid-β Oligomers Requires Lipid Rafts and the Transmembrane LRP1*

  2013cited by this paper
• Roles of endoproteolytic α‐cleavage and shedding of the prion protein in neurodegeneration

  2013cited by this paper
• Exosomes neutralize synaptic-plasticity-disrupting activity of Aβ assemblies in vivo

  2013cited by this paper
• Increased prion protein processing and expression of metabotropic glutamate receptor 1 in a mouse model of Alzheimer's disease

  2013cited by this paper
• The cellular prion protein traps Alzheimer's Aβ in an oligomeric form and disassembles amyloid fibers

  2013cited by this paper
• Exosomal cell-to-cell transmission of alpha synuclein oligomers

  2012cited by this paper
• TAL Effector-Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target prediction

  2012cited by this paper
• Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation

  2012influential reference
• Alzheimer Amyloid-β Oligomer Bound to Post-Synaptic Prion Protein Activates Fyn to Impair Neurons

  2012cited by this paper
• The Complex PrPc-Fyn Couples Human Oligomeric Aβ with Pathological Tau Changes in Alzheimer's Disease

  2012influential reference
• Exosomes: Vehicles for the Transfer of Toxic Proteins Associated with Neurodegenerative Diseases?

  2012cited by this paper
• Sphingolipid-modulated Exosome Secretion Promotes Clearance of Amyloid-β by Microglia

  2012influential reference
• Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes.

  2012cited by this paper
• Soluble Prion Protein Inhibits Amyloid-β (Aβ) Fibrillization and Toxicity*

  2012cited by this paper
• Separate mechanisms act concurrently to shed and release the prion protein from the cell

  2012cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Biochemical methane potential (BMP) of solid organic substrates: evaluation of anaerobic biodegradability using data from an international interlaboratory study

  2011cited by this paper
• Deciphering the molecular details for the binding of the prion protein to main ganglioside GM1 of neuronal membranes.

  2011cited by this paper
• The cellular prion protein mediates neurotoxic signalling of β‐sheet‐rich conformers independent of prion replication

  2011cited by this paper
• Cellular Prion Protein Mediates Toxic Signaling of Amyloid Beta

  2011cited by this paper
• Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites

  2011cited by this paper
• Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting

  2011influential reference
• Alzheimer's Disease Brain-Derived Amyloid-β-Mediated Inhibition of LTP In Vivo Is Prevented by Immunotargeting Cellular Prion Protein

  2011cited by this paper
• Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis

  2011influential reference
• The Extracellular Regulated Kinase-1 (ERK1) Controls Regulated α-Secretase-mediated Processing, Promoter Transactivation, and mRNA Levels of the Cellular Prion Protein*

  2011cited by this paper
• The extracellular regulated kinase-1 (ERK1) controls regulated α-secretase-mediated processing, promoter transactivation, and mRNA levels of the cellular prion protein.

  2011cited by this paper
• Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo

  2011cited by this paper
• Memory Impairment in Transgenic Alzheimer Mice Requires Cellular Prion Protein

  2010cited by this paper
• Amyloid β-Protein Dimers Rapidly Form Stable Synaptotoxic Protofibrils

  2010cited by this paper
• Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein

  2010cited by this paper
• A physiological role for amyloid-beta protein:enhancement of learning and memory.

  2010cited by this paper
• Supplementary figure legends

  2010cited by this paper
• The prion protein as a receptor for amyloid-β

  2010cited by this paper
• Anti-PrP monoclonal antibody infusion as a novel treatment for cognitive deficits in an alzheimer’s disease model mouse

  2010cited by this paper
• A Physiological Role for Amyloid-β Protein: Enhancement of Learning and Memory

  2010cited by this paper
• Alzheimer's disease.

  2010cited by this paper
• Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5.

  2010cited by this paper
• Prion protein in Alzheimer's pathogenesis: a hot and controversial issue

  2010cited by this paper
• Cellular Prion Protein Mediates Impairment of Synaptic Plasticity by Amyloid-β Oligomers

  2009cited by this paper
• Faculty Opinions recommendation of Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.

  2009influential reference
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• A Simple Cipher Governs DNA Recognition by TAL Effectors

  2009cited by this paper
• Up-and-down topological mode of amyloid β-peptide lying on hydrophilic/hydrophobic interface of ganglioside clusters

  2009cited by this paper
• Exosomes--vesicular carriers for intercellular communication.

  2009influential reference
• Quantifying protein by bicinchoninic Acid.

  2008cited by this paper
• Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid.

  2008cited by this paper
• Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

  2008cited by this paper
• Alzheimer's disease beta-amyloid peptides are released in association with exosomes.

  2006influential reference
• A specific amyloid-beta protein assembly in the brain impairs memory.

  2006cited by this paper
• A specific amyloid-β protein assembly in the brain impairs memory

  2006cited by this paper
• ReviewTwenty Years of the Alzheimer ’ s Disease Amyloid Hypothesis : A Genetic Perspective

  2005cited by this paper
• Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.

  2005cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

  2002cited by this paper
• Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region.

  2001cited by this paper
• Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain.

  2000cited by this paper
• Prions prevent neuronal cell-line death

  1999cited by this paper
• A constrained regularization method for inverting data represented by linear algebraic or integral equations

  1982cited by this paper

• Tissue-Derived Small Extracellular Vesicles: Emerging Regulators of Inter-Organ Crosstalk in Health and Disease

  2026cites this paper
• Evaluation of the Effects of Nano-Oleocanthal on Histopathological Changes and the Expression of APP and PRNP Genes in an Alzheimer’s Rat Model

  2026cites this paper
• Biology and therapeutic potential of extracellular vesicle targeting and uptake.

  2026cites this paper
• Exosome/Extracellular Vesicles-Based Therapeutics in Alzheimer’s Disease: Neuroprotective Roles and Future Perspectives

  2025cites this paper
• Proteolytic activities of extracellular vesicles attenuate A-synuclein aggregation

  2025cites this paper
• Central Nervous System-Derived Extracellular Vesicles as Biomarkers in Alzheimer’s Disease

  2025cites this paper
• Adipose Mesenchymal Stem Cell‐Derived Exosomes in Conjunction with Roflumilast Ameliorate Chronic Kidney Disease Through the Modulation of Fibrosis and Inflammation

  2025cites this paper
• Whispers in the Brain: Extracellular Vesicles in Neuropathology and the Diagnostic Alchemy of Neurological Diseases

  2025cites this paper
• Chaihu-Shugan-San Alleviates Post-Stroke Depression in Mice: Mechanistic Insights into Exosome-Mediated Neuroprotection.

  2025cites this paper
• Advancing Alzheimer's disease therapy through engineered exosomal Macromolecules.

  2025cites this paper
• Efficient enzyme-free isolation of brain-derived extracellular vesicles

  2024cites this paper
• The complexity of extracellular vesicles: Bridging the gap between cellular communication and neuropathology

  2024cites this paper
• Exosomal miR-126: Unveiling Its Diagnostic and Therapeutic Potential in Chronic Kidney Disease

  2024cites this paper
• Interlaminar and varicose-projection astrocytes: toward a new understanding of the primate brain

  2024cites this paper
• Efficient enzyme‐free isolation of brain‐derived extracellular vesicles

  2024cites this paper
• Exploring the multiple therapeutic mechanisms and challenges of mesenchymal stem cell-derived exosomes in Alzheimer's disease.

  2024cites this paper
• Comment on “Extracellular Vesicles Slow Down Aβ(1–42) Aggregation by Interfering with the Amyloid Fibril Elongation Step”

  2024cites this paper
• An Atypical Case of Creutzfeldt-Jakob Syndrome Presenting with Cacosmia and Amyloid Positivity

  2024cites this paper
• Upregulated PrPC by HBx enhances NF-κB signal via liquid–liquid phase separation to advance liver cancer

  2024cites this paper
• Lack of cellular prion protein causes Amyloid β accumulation, increased extracellular vesicle abundance, and changes to exosome biogenesis proteins

  2024cites this paper
• Unveiling the Complex Role of Exosomes in Alzheimer’s Disease

  2024cites this paper
• Tailor-made nanocargoes as promising tool for brain targeting: Modulated approaches with better therapeutic outcomes

  2023cites this paper
• Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseases

  2023cites this paper
• The role of PrPc in Alzheimer's disease related Amyloid-β hypothesis: a systematic review

  2023cites this paper
• Endothelial Senescence and Its Impact on Angiogenesis in Alzheimer’s Disease

  2023cites this paper
• The emerging double-edged sword role of exosomes in Alzheimer’s disease

  2023cites this paper
• Small extracellular vesicles: a novel drug delivery system for neurodegenerative disorders

  2023cites this paper
• Small Extracellular Vesicles’ miRNAs: Biomarkers and Therapeutics for Neurodegenerative Diseases

  2023cites this paper
• Inducing prion protein shedding as a neuroprotective and regenerative approach in pathological conditions of the brain: from theory to facts

  2023influential citation
• The Potential Roles of Exosomes Carrying APP and Tau Cleavage Products in Alzheimer’s Disease

  2023cites this paper
• Prion receptors, prion internalization, intra- and inter-cellular transport.

  2023cites this paper
• Neuronal deletion of nSMase2 reduces the production of Aβ and directly protects neurons.

  2023cites this paper
• Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein

  2022cites this paper
• Emerging Roles of Extracellular Vesicles in Alzheimer’s Disease: Focus on Synaptic Dysfunction and Vesicle–Neuron Interaction

  2022cites this paper
• Huntingtin and Other Neurodegeneration-Associated Proteins in the Development of Intracellular Pathologies: Potential Target Search for Therapeutic Intervention

  2022cites this paper
• Vascular smooth muscle cell senescence accelerates medin aggregation via small extracellular vesicle secretion and extracellular matrix reorganization

  2022cites this paper
• Dual action of exosomes derived from in vitro Aβ toxicity model: The role of age for pathological response.

  2022cites this paper
• From Promise to Reality: Bioengineering Strategies to Enhance the Therapeutic Potential of Extracellular Vesicles

  2022cites this paper
• Extracellular vesicles: A new paradigm in understanding, diagnosing and treating neurodegenerative disease

  2022influential citation
• The Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer’s Disease

  2022cites this paper
• Exosomes derived from bone marrow mesenchymal stem cells inhibit human aortic vascular smooth muscle cells calcification via the miR-15a/15b/16/NFATc3/OCN axis.

  2022cites this paper
• Immuno-digital invasive cleavage assay for analyzing Alzheimer’s amyloid ß-bound extracellular vesicles

  2022cites this paper
• Exosomes in schizophrenia: Pathophysiological mechanisms, biomarkers, and therapeutic targets

  2022cites this paper
• The multiple functions of PrPC in physiological, cancer, and neurodegenerative contexts

  2022cites this paper
• Neuroprotective Effects of Astrocyte Extracellular Vesicles in Stroke

  2022cites this paper
• Recent Advances on the Function and Purification of Milk Exosomes: A Review

  2022cites this paper
• Exosomes and MicroRNAs in Biomedical Science

  2022cites this paper
• KIBRA regulates amyloid β metabolism by controlling extracellular vesicles secretion

  2022cites this paper
• Lipidomic analysis identifies age-disease-related changes and potential new biomarkers in brain-derived extracellular vesicles from metachromatic leukodystrophy mice

  2022cites this paper
• Reactive Astrocytes Contribute to Alzheimer’s Disease-Related Neurotoxicity and Synaptotoxicity in a Neuron-Astrocyte Co-culture Assay

  2022cites this paper
• Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis

  2022cites this paper
• Gene-Edited Cell Models to Study Chronic Wasting Disease

  2022cites this paper
• The prion protein and its ligands: Insights into structure-function relationships.

  2022cites this paper
• Prion Protein: The Molecule of Many Forms and Faces

  2022cites this paper
• Ligands binding to the cellular prion protein induce its protective proteolytic release with therapeutic potential in neurodegenerative proteinopathies

  2021cites this paper
• Brain-Derived Extracellular Vesicles in Health and Disease: A Methodological Perspective

  2021cites this paper
• Recent Advances on Extracellular Vesicles in Central Nervous System Diseases

  2021cites this paper
• Extracellular vesicle concentrations of glial fibrillary acidic protein and neurofilament light measured 1 year after traumatic brain injury

  2021cites this paper
• Astrocyte-derived extracellular vesicles: a double-edged sword in central nervous system disorders.

  2021cites this paper
• Prion protein oligomers cause neuronal cytoskeletal damage in rapidly progressive Alzheimer’s disease

  2021cites this paper
• Accumulation of cellular prion protein within β‐amyloid oligomer plaques in aged human brains

  2021cites this paper
• Amyloid-β: A double agent in Alzheimer's disease?

  2021cites this paper
• Function of exosomes in neurological disorders and brain tumors

  2021cites this paper
• Prion Protein of Extracellular Vesicle Regulates the Progression of Colorectal Cancer

  2021cites this paper
• Exosomes: Innocent Bystanders or Critical Culprits in Neurodegenerative Diseases

  2021cites this paper
• Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part I. a literature review

  2021cites this paper
• Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part II: strategies for therapeutics development

  2021cites this paper
• Distinct types of amyloid‐β oligomers displaying diverse neurotoxicity mechanisms in Alzheimer's disease

  2021cites this paper
• Extracellular Vesicles in Premature Aging and Diseases in Adulthood Due to Developmental Exposures

  2021cites this paper
• Brain Exosomes: Friend or Foe in Alzheimer’s Disease?

  2021cites this paper
• The promise of exosome applications in treating central nervous system diseases

  2021cites this paper
• Extracellular Vesicles Taken up by Astrocytes

  2021cites this paper
• Role of brain extracellular vesicles in air pollution-related cognitive impairment and neurodegeneration.

  2021cites this paper
• A Soluble PrPC Derivative and Membrane-Anchored PrPC in Extracellular Vesicles Attenuate Innate Immunity by Engaging the NMDA-R/LRP1 Receptor Complex

  2021cites this paper
• Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies

  2021cites this paper
• Recent Advances on Extracellular Vesicles in Central Nervous System Diseases

  2021cites this paper
• Recent Advances on Extracellular Vesicles in Central Nervous System Diseases

  2021cites this paper
• The role of exosome lipids in central nervous system diseases

  2020cites this paper
• Exosomes: A new horizon in modern medicine.

  2020cites this paper
• Exosomes in Disease and Regeneration: Biological Functions, Diagnostics and Beneficial Effects.

  2020cites this paper
• ADSCs-derived extracellular vesicles alleviate neuronal damage, promote neurogenesis and rescue memory loss in mice with Alzheimer's disease.

  2020cites this paper
• Insights Into the Proteomic Profiling of Extracellular Vesicles for the Identification of Early Biomarkers of Neurodegeneration

  2020cites this paper
• Extracellular Vesicles in Alzheimer’s and Parkinson’s Disease: Small Entities with Large Consequences

  2020cites this paper
• Characterization of brain-derived extracellular vesicles reveals changes in cellular origin after stroke and enrichment of the prion protein with a potential role in cellular uptake

  2020cites this paper
• The interplay between aging‐associated loss of protein homeostasis and extracellular vesicles in neurodegeneration

  2020cites this paper
• Show Me Your Friends and I Tell You Who You Are: The Many Facets of Prion Protein in Stroke

  2020cites this paper
• Alzheimer’s disease progression characterized by alterations in the molecular profiles and biogenesis of brain extracellular vesicles

  2020cites this paper
• Transgenic Overexpression of the Disordered Prion Protein N1 Fragment in Mice Does Not Protect Against Neurodegenerative Diseases Due to Impaired ER Translocation

  2020cites this paper
• Astrocytes deliver CK1 to neurons via extracellular vesicles in response to inflammation promoting the translation and amyloidogenic processing of APP

  2020cites this paper
• The biology, function, and biomedical applications of exosomes

  2020cites this paper
• Transmissible Endosomal Intoxication: A Balance between Exosomes and Lysosomes at the Basis of Intercellular Amyloid Propagation

  2020cites this paper
• Extracellular vesicles in neurodegenerative disorders

  2020cites this paper
• “Dual Disease” TgAD/GSS mice exhibit enhanced Alzheimer’s disease pathology and reveal PrPC-dependent secretion of Aβ

  2019cites this paper
• The characterization of AD/PART co-pathology in CJD suggests independent pathogenic mechanisms and no cross-seeding between misfolded Aβ and prion proteins

  2019cites this paper
• Role of Extracellular Vesicles on Immune Regulation in an Animal Model of Multiple Sclerosis

  2019cites this paper
• Brain-Derived Extracellular Vesicles are Highly Enriched in the Prion Protein and Its C1 Fragment: Relevance for Cellular Uptake and Implications in Stroke

  2019cites this paper
• Preferential Recruitment of Conformationally Distinct Amyloid-β Oligomers by the Intrinsically Disordered Region of the Human Prion Protein.

  2019cites this paper
• The Propagation of Neurodegenerative Diseases by Inflammation and Exosomes

  2019cites this paper
• Extracellular Vesicles: Mechanisms in Human Health and Disease.

  2019cites this paper
• Extracellular vesicles in the diagnosis and treatment of central nervous system diseases

  2019cites this paper